Open AccessMiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2
Author(s) -
ZhiDong Lv,
Di Yang,
Xiangping Liu,
Lina Jin,
Xingang Wang,
Zhaochuan Yang,
Dong Liu,
Jiaojiao Zhao,
Bin Kong,
Funian Li,
Haibo Wang
Publication year - 2017
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000485785
Subject(s) - triple negative breast cancer , downregulation and upregulation , cancer research , vimentin , epithelial–mesenchymal transition , ectopic expression , breast cancer , microrna , cancer , biology , western blot , medicine , immunohistochemistry , cell culture , immunology , gene , biochemistry , genetics
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype. Our study investigated the functional role of miR-212-5p in TNBC.